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Hemodialysis membrane-induced activation of phagocyte oxidative
metabolism detected in vivo and in vitro within microamounts of whole
blood. The production of reactive oxygen species by phagocytes from
uremic patients undergoing hemodialysis was monitored by chemilumi-
nescence (CL) within microamounts of whole blood or isolated poly-
morphonuclear (PMN) cells, and compared on the basis of the dialysis
membrane, cuprophane (CUP) or polyacrilonitrile (PAN). Compared to
control subjects, resting and stimulated CL (with latex, zymosan,
phorbol mynstate acetate (PMA) but not formyl-methionyl-leucyl-
phenylalanine (FMLP) were decreased in 10-2 diluted blood sampled
before dialysis. After 15 mm of dialysis (ti), resting whole blood (10
and 10_2 diluted) CL increased sharply in patients dialyzed with the
CUP but not the PAN membrane, while it returned to its predialysis
level at the end of the session. This sharp resting CL increase found in
whole blood at ti was not observed in isolated PMN cells except when
tested with ti plasma from CUP dialyzed patients, suggesting that it was
mediated via activated plasma compounds. In vitro treatment of normal
blood, plasma, and isolated PMN cells with CUP membrane fragments
reproduced this in vivo dialysis-induced activation of phagocyte oxida-
tive metabolism strikingly and demonstrated additionally the require-
ment of complement for its induction. We propose this model as an
effective means of evaluating dialysis membrane biocompatibility.
Influence de l'hémodialyse sur l'activité metabolique oxydative des
cellules phagocytaires de sujets insuffisants rénaux chroniques. L'activité
métabolique oxydative des cellules phagocytaires a détermine par
chimioluminescence (CL) au scm de microëchantillons de sang total
dilué et de suspensions de polynucléaires (PN) isolés, prélevés a divers
moments au cours de Ia scéance de dialyse (to, t15min, t final) chez des
sujets dialyses avec cuprophane (CUP) ou polyacrylonitrile (PAN).A
to, Ia CL basale ou stimulCe (par latex, zymosan, ou PMA) du sang (au
1/100) est significativement plus faible que chez les témoins normaux. A
t1, mm, Ia CL basale augmente dans le sang (au 1/10 et 1/100) des
dialyses avec CUP mais non PAN, puis, a t final, revient a son taux de
to. Ce pic de CL n'est pas retrouvC dans les PN isolés sauf si ceux-ci
sont testes en presence de plasma autologue preleve a t15 mm (mais non
to) chez les dialyses avec CUP (mais non PAN). Cette activation
métabolique oxydative des cellules phagocytaires induite in vivo par
CUP peut être reproduite in vitro au sein de microCchantillons de sang
de sujets normaux et, en partie, étre expliquée par Ia genese de facteurs
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du complement activés. Ce modèle de CL peut Ctre propose comme
mCthode d'Cvaluation de Ia biocompatibilité des membranes de dialyse.
Clinical evidence indicates that bacterial infections are still a
frequent cause of morbidity and mortality in uremic patients
maintained on long-term hemodialysis [1, 21. This increased
susceptibility to infections has been related to various dysfunc-
tions of polymorphonuclear (PMN) cells observed in vitro, such
as altered adhesiveness [3], defective chemotactic responsive-
ness [4, 5], and impairment of phagocytic and bactericidal
capacities [5].
More recently, some authors reported significant alterations
in PMN chemiluminescence (CL) production, which is a well-
established and sensitive means for measuring the production of
reactive oxygen species (ROS) by phagocytes, and correlates
well with bactericidal activity [6—8]. However, these alterations
seem to depend upon the time during the dialysis session [7, 8],
and to be influenced diversely by the patient's serum [6, 7].
It now has been well documented also that hemodialysis
induces pronounced but transient leukopenia [9, 10]. This
leukopenia, which reaches a nadir by 10 to 20 mm following the
start of hemodialysis, has been explained recently by the
generation of activated complement fragments following the
interaction of plasma with the dialysis membrane, which leads
to the sequestration of blood leukocytes in the pulmonary
vascular bed [11, 12].
A possible role of the type of dialysis membrane in this
leukopenia has been suggested by other authors [13]. In our
dialysis center, Tien et a! [14] compared a noncellulosic mem-
brane (polyacrylonitrile AN—69, PAN) and the cellulosic
cuprophane (CUP) membrane, and found important differences
in hemodialysis-induced changes in leukocyte numbers and
complement activation. They suggested that the chemical struc-
ture of the membranes could contribute to the genesis of plasma
factors having potent effects on granulocyte functions.
Using an in vitro assay that mirrors closely the in vivo
situation since it determines phagocyte oxidative metabolism
within microamounts of whole blood [15], we undertook the
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present study with the following aims: 1) to compare the
oxidative metabolism of phagocytes from dialyzed patients to
those from normal individuals in the absence and in the pres-
ence of a panel of particulate and soluble stimulating agents; 2)
to follow the evolution of these oxidative responses during the
course of the dialysis session; 3) to analyze the influence of
cellulosic versus noncellulosic dialysis membranes on this
phagocyte function by evaluating their effects on plasma con-
stituents and phagocytic cells; and 4) to attempt to determine
the respective participation of these two blood components in
the reaction by studying the effect of autologous plasma on the
oxidative metabolism of PMN isolated from whole blood. We
propose that this mode of detecting dialysis membrane-induced
changes in plasma and/or phagocyte activity could be useful in
the in vitro evaluation of membrane biocompatibility.
Methods
Subjects
Forty-four healthy adult volunteers were used as control
subjects. Thirty-five patients, all established in stable, long-
term hemodialysis programs following end-stage renal failure,
were selected. Their mean age was 47 years (ranging from 16 to
79 years). There were 17 men and 18 women. Distribution of
primary renal disease did not differ greatly from that of the
general dialysis population (glomerulonephritis, 12; pyelone-
phritis, 6; polycystic kidney, 1; renal vascular disease, 2;
heredofamilial nephropathy, 2; unknown etiology, 9; and oth-
ers, 3). All were dialyzed thrice weekly for 4 to 5 hr, except for
one who was dialyzed twice weekly. Thirteen patients were
dialyzed with a disposable plate kidney equipped with a PAN
membrane and the other 22 patients with CUP capillary mem-
branes. The surface area in both cases was ito 1.4 m2.
Blood, plasma, and PMN cells
Blood samples were drawn from the arterial line at the start
(to), at 15 mm (ti), and at the end (tO of dialysis sessions. For
ROS determination, 0.5 ml blood samples were collected in
tubes containing heparin (Liquemine, Roche, Paris, France, 10
U/ml of blood), diluted (10-' and 10-2) in HBSS, and tested
immediately; simultaneously, 2.5 ml blood aliquots were col-
lected in tubes containing EDTA for leukocyte differential
counts. For experiments with isolated blood constituents (PMN
cells and/or plasma), 10 to 15 ml blood samples were collected
in heparinized tubes. Plasma was separated by centrifugation
(600g x 10 mm). PMN cells were isolated by a two-step
procedure described previously [16], that is, a sedimentation
through Ficoll-Paque (Pharmacia Fine Chemicals, Uppsala,
Sweden) followed by a 5% Dextran (Pharmacia) sedimentation
and subsequent erythrocyte lysis with ammonium chloride.
Reagents
Phenol red free Hanks' balanced salt solution (HBSS) ob-
tained from Eurobio (Paris, France) was used for suspending
cells and diluting reagents.
Luminol (5-amino-2,3-dihydro-1,4-phthalazinedione; Sigma,
St. Louis, Missouri, USA) was dissolved in dimethylsulfoxide
(DMSO, Prolabo, Paris, France) at a concentration of 2 mglml
and maintained in the dark as a stock solution. Immediately
before testing, one aliquot was further diluted 1:10 in HBSS and
used as the test solution.
Bacto latex particles (0.81 tm), in a suspension containing
2.5 x i09 particles/mi, were purchased from Difco Laboratories
(Detroit, Michigan, USA).
Serum-treated zymosan was prepared according to Reiss and
Roos [17]. Briefly, zymosan from Sigma was suspended in
saline (20 mg/mI equalling approximately io particles/mi),
boiled for 60 mm, washed twice, and resuspended at the same
concentration in fresh human AB serum, incubated for 30 mm
at 37°C, washed once with saline, resuspended in HBSS at the
concentration of 20 mg/ml, and stored at —20°C.
Phorbol myristate acetate (PMA) (4 3-phorbol 12 /3-myristate
13 a-acetate) from Sigma was dissolved in DMSO at a concen-
tration of 1 mg/mI, and 1 ml aliquots were stored at 4°C.
Immediately before testing, the PMA solution was diluted 1:100
in HBSS.
N-formyl-methionyl-leucyl-phenylalanine (FMLP) from Sig-
ma was dissolved in DMSO at a concentration of 10 mg/mI and
stored at 4°C. Immediately before testing, the FMLP solution
was diluted 1:100 in HBSS.
Determination of ROS production
ROS production was determined by luminol-dependent
chemiluminescence (CL), according to a previously described
method for evaluation of this phagocyte oxidative function,
which has become a routine test in our laboratory [15].
Briefly, 100 ti of l0' or 102 diluted blood were transferred
into a counting tube, containing 10 pi of HBSS alone or the
appropriately diluted stimulating agent [15]. The tube was
incubated in a dry bath (Thermolyne, Dubuque, Iowa, USA) at
37°C and agitated constantly at 120 rpm (Gyrotory shaker model
G2, New Brunswick Scientific Co., Inc., Edison, New Jersey,
USA). Ten mm later, 50 pJ of the luminol test solution were
added and the tube was introduced into the photometer
(Biolumat LB 9500, Berthold, Widbad, Germany) dark cham-
ber. The photon counting value, which is indicated arbitrarily in
relative light units (RLU) by the photometer, was taken after 5
sec, a time revealed to be sufficient for photon equilibrium in
whole blood (standard deviation (SD) between triplicate sam-
pies < 5% of the mean). According to our previous study [15]
showing that the CL intensity is (at least within the 10' to 10_2
dilution range) proportional to the number of phagocytes, the
measured CL values were expressed per iO phagocytes (PMN
cells and monocytes MN). Indeed, we showed previously that
this mode of calculation provides an accurate determination of
the range of CL production among normal individuals, and thus
detects phagocyte oxidative metabolism dysfunctions [15, 18,
19].
For 20 patients, ROS produced by PMN cells isolated from to
and ti blood samples were also determined as described previ-
ously [16].
In vitro studies of dialysis membrane-induced
ROS production
Calibrated CUP or PAN membrane fragments were incu-
bated at 37°C for different time periods, with whole blood at
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varied membrane surface/blood volume (MS/BY) ratios (see
Results) or with isolated PMN cell suspensions at a constant
membrane surface/cell number ratio (1 cm2 per 3 X io cells).
At the end of the incubation, CL was determined in triplicate
samples (100 1.d) of each MS/BY combination supernatant. In
experiments using isolated cell suspensions, CL production was
determined in the presence of membrane fragments. Kinetic
studies of light emission after luminol addition revealed that in
this particular series of in vitro studies a 2-mm incubation with
luminol was necessary before CL measuring.
Study of the influence ofplasma
The influence of autologous plasma on ROS production by
isolated PMN cells from dialyzed patients was studied by cross
incubating PMN cells with plasma collected at to and ti. Due to
the profound neutropenia observed in some patients at ti, to and
ti PMN cells were resuspended in either to or ti plasma diluted
(10) at the low concentration of 5 x iO cells/mi.
The influence of dialysis membrane-treated normal plasma
was studied by incubating CUP or PAN membrane fragments
with normal undiluted plasma (2 cm2/iOO pi) for 30 mm at 37°C
and testing the effect of this treated plasma on autologous PMN
cells resuspended volume to volume in order to obtain a PMN
cell concentration of 3 x 106 cells/ml, approximating that
present in normal whole blood.
Statistical analyses were made using either the Student's
test or the paired t test, depending upon the type of sample
groups (unpaired or paired) to be compared.
Results
Influence of hemodialysis on blood leukocyte counts
Comparison of differential white blood cell counts made at to
with those found in normal subjects showed no statistically
significant differences.
L As shown on Figure 1, 15 mm after the beginning of
T hemodialysis (ti), the mean PMN count was decreased dramat-
ically from its level before hemodialysis (P < 0.01). The mean
MN cell count was diminished also, although less markedly (P
< 0.05) at ti. By the end of hemodialysis (ti), both PMN and
MN cell counts had returned to their predialysis levels.
In contrast, the mean lymphocyte counts remained un-
changed, regardless of the time of determination.
Influence of hemodialysis on ROS production in whole blood
ROS production was evaluated in diluted blood samples from
dialyzed patients taken at to, ti, and tf during the dialysis
session, and both in the absence (HBSS) and in the presence of
the various particulate (latex, zymosan) or soluble stimulating
agents (PMA, FMLP) (Fig. 2).
Regardless of the time of blood sampling during dialysis, a
marked increase in CL intensity was observed when the blood
was diluted from 10_I to 102. Similar results were observed in
our previous study [15], where, using a constant source of light
emission, we demonstrated that this CL increase at lower blood
concentrations is due in fact to the dilution of the quenching
effect of blood components (red blood cells and plasma constit-
uents) on photon captation. In parallel, we previously also
verified that in this model using whole blood, luminol-
dependent CL emission is only produced by phagocytic cells
and not by red blood cells, lymphocytes, platelets, or plasma
constituents.
Before the start of hemodialysis (to), ROS production evalu-
ated in uremic patients (all cases) did not differ greatly from that
of normal control subjects when determined in 10 diluted
blood regardless of the cell state or the stimulating agent (Fig.
2A), whereas it was reduced significantly in iO_2 diluted blood
(Fig. 2B). This significantly decreased ROS production in low
plasma concentrations occurred both in the presence of medium
alone (HBSS, P < 0.01), as well as in the presence of stimulat-
ing agents, such as latex (P < 0.001), serum-treated zymosan (P
<0.05), and PMA (P < 0.05), but not FMLP.
Fifteen mm after the beginning of hemodialysis (ti), dramatic
increases in resting CL emissions were found in both 10 and
102 diluted blood samples, compared to to levels (P <0.01). In
contrast, CL responses to stimulating agents were not altered
consistently; only the CL response to PMA determined in i0
diluted blood was significantly reduceI(P < 0.01).
At the end of hemodialysis (ti'), resting £L production re-
turned to predialysis levels, the evolution of the CL response to
stimulating agents was dependent upon the type of agent:
regardless of the blood dilution, CL responses to latex and
FMLP remained unaffected, whereas those to serum-treated
zymosan particles were significantly increased compared to
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Fig. 1. Influence of hemodialysis on the mean SEMdifferential white
blood cell counts, that is, lymphocytes (L), monocyzes (MN), and
polymorphonuclear cells (PMN), as determined before (to), 15 mm
after the onset (ti), and at the end (tO of the dialysis session in 35
patients.
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Fig. 2. In vivo influence of hemodialysis on ROS production in whole blood from 35 patients. CL responses in the presence of the agents indicated
on the abcissa were determined in 10—' (A) and 10_2 (B) diluted blood samples taken before, 15 mm after the onset, and at the end of the dialysis
session and are expressed per i0 PMN + MN cells. CL results from 44 normal subjects tested previously in our laboratory served as the reference
control population. Asterisks indicate the level of statistical significance between the groups indicated under the bracket: * = P < 0.05; ** = P
< 0.01; and *** = P < 0.001. The absence of a bracket indicates that the difference is not significant. Symbols are: , control subjects; •,
hemodialyzed patients before dialysis; , hemodialyzed patients 15 mm after beginning hemodialysis; t-t, hemodialyzed patients at the end of
hemodialysis.
their levels at to and ti. Similarly, CL responses to PMA were
significantly increased compared to their levels at to and ti in
10 diluted blood and at ti in 10-2 diluted blood.
Influence of dialysis membranes on blood leukocyte counts
Figure 3 shows that the evolution of PMN and MN counts
during hemodialysis differed markedly according to the type of
dialysis membrane used. With PAN dialysis membranes, no
changes in either PMN, MN, or lymphocyte (L) mean counts
were noted, regardless of the time of testing. However, with
CUP membranes, pronounced neutropenia and monocytopenia
were observed at ti. The differences observed at ti between the
two types of membranes are statistically significant but, again,
mean lymphocyte counts remained unchanged.
Influence of dialysis membranes on ROS production in
whole blood
Figures 4 and 5 show that the patterns of ROS production in
diluted whole blood from dialyzed patients differed strikingly
according to the type of dialysis membrane used. With PAN
membranes, CL emission patterns remained unchanged during
hemodialysis, regardless of the cell state (resting or stimulated)
or the blood sample dilution (10-' and 10-2; Figs. 4A and B,
respectively). In contrast, marked changes in ROS production
were found with CUP membranes (Figs. 5A and B). These
modifications affecting both resting CL and zymosan- or PMA-
induced CL demonstrate that CUP dialysis membranes were
responsible for the CL changes observed in the overall patient
population (Fig. 2).
Influence of hemodialysis on ROS production by isolated
PMN cells
The oxidative metabolism of PMN cell suspensions (> 95%
purity) was studied in 20 patients, including 12 patients treated
with CUP dialysis membranes and eight patients with PAN
dialysis membranes. ROS production was determined in the
absence (HBSS) and in the presence of particulate (zymosan) or
soluble (PMi) stimulating agents.
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Fig. 3. Comparative study of the in vivo influence of dialysis membranes
on the dialysis-induced leukopenia. The mean SEM differential white
blood cell counts, lymphocytes (L), monocytes (MN), and polymar-
phonuclear cells (PMN), were determined before (to), 15 mm after the
onset (ti), and at the end (t of the dialysis session. Twenty-two patients
dialyzed with CUP were compared with 13 patients dialyzed with PAN
dialysis membranes. The differences observed between to and ti MN
and PMN cell counts in CUP-dialyzed patients are statistically signifi-
cant (P < 0.05and P < 0.01, respectively). Symbols are O—-—-.0, PAN
membrane: A----A, CUP membrane.
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In PMN cell suspensions from to blood samples, compared to
39 normal control subjects, mean CL production/103 PMN cells
was unchanged in the presence of HBSS (respectively 89 9.7
vs. 97 22) or PMA (558 45 vs. 505 74). In contrast,
zymosan-induced CL responses were significantly depressed in
dialyzed patients (1377 106 vs. 862 113, P < 0.01).
Table I analyzes the influence of dialysis membranes on the
PMN cell capacity to produce ROS. Regardless of the time of
dialysis, ROS production was higher in CUP- than in PAN-
treated patients; the differences observed, however, are not
statistically significant. Table 1 shows also that, in contrast with
results obtained in whole blood (Fig. 5), ROS production by
PMN cells did not increase at ti. These findings led us to study
the influence of to versus ti plasma upon ROS generation by
autologous isolated PMN cells.
Influence of autologous plasma on ROS production by
PMN cells
The influence of predialysis (to) and early (ti) perdialysis
autologous plasmas on ROS production by PMN cells from
patients treated with CUP or PAN membranes is shown in
Table 2. In the former group, resting ROS production by PMN
cells was increased markedly after mixing with autologous
plasma sampled at ti, compared to that sampled at to. The
differences were statistically significant with PMN cells from to
but not from ti.
In contrast, PMN cells from patients treated with PAN
membranes did not show increased ROS generation in the
presence of early perdialysis plasma.
In vitro effect of dialysis membranes on ROS production by
whole blood from normal subjects
Figure 6 shows a kinetic study of the in vitro effects of CUP
or PAN membranes on resting CL generation by pure whole
blood samples from five normal individuals.
In these experiments, blood samples (500 pA) were incubated
at 37°C under constant agitation with a 5 cm2 fragment of each
membrane. ROS production was measured in blood aliquots
(100 pA) taken at the times indicated on the figure. The increased
CL emissions observed at 15 and 30 mm in the samples in
contact with CUP membranes were statistically significant
B
-J
00
•0
CO
CO
CO
00
C)
CO
0.
0
CO
C.
-J0
A
HBSS
-J
00
-C
0)
C
(0
0)
>.
C.)0
C)
CO
-cC.
C.,0
0)
C.
-J0
10 .I100l
Latex Zymosan
100_I T
100—
HBSS Latex Zymosan
5-
3-
B
Fig. 4. In vivo influence of hemodia/ysis on ROS production in whole blood from 13 patients dialyzed with PAN membranes (see Fig. 2). Symbols
are: hemodialyzed patients using PAN membrane before dialysis, •; 15 mm after beginning of dialysis, at the end of the dialysis, E.
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Fig. 5. In viva influence of hemodialysis on ROS production in whole blood from 22 patients dialyzed with CUP membranes (see Fig. 2). Symbols
are: hemodialyzed patients using CUP membrane before dialysis, ; 15 mm after beginning of hemodialysis, at the end of hemodialysis, ,
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Agent
CL production by
di
l0 PMN cells from patients
alyzed using
CUP Membrane PAN membrane
to ti to ti
HBSS
Zymosan
PMA
153
1249
757
56 92
374 815
283 721
32 77 27 74
302 783 88 659
271 394 65 361
19
176
55
Abbreviations are: to, predialysis time; ti, 15 mm after beginning of
dialysis.
Table 2. Influence of autologous plasma on ROS production by PMN
cells from dialyzed patients: comparative studies between predialysis
and early perdialysis plasmas in patients dialyzed with cuprophane or
polyacrylonitrile membranes
CL production by 10
patients dialy
PMN cells from
zed using
CUP membrane PAN membrane
to ti to ti
compared to those in contact with PAN or no membrane (P <
0.05 using the paired t test).
In an attempt to investigate whether this in vitro effect of
CUP membranes on whole blood CL production could be
dose dependent, the two following series of experiments were
performed.
In the first series of six experiments illustrated in Figure 7,
the ratio between membrane surface and blood volume
(MS/BV) was maintained constant (10 cm2/ml), but the blood
concentration was varied. ROS production 30 mm after the
initiation of contact with membranes at 37°C was much higher
in the samples incubated with CUP than with PAN membranes.
In the second series of three experiments, the membrane
surface was varied, while both whole blood concentration (1/10
diluted) and volume (100 jsl) were maintained otherwise con-
stant. As shown in Figure 8, blood samples in contact with
increasing CUP fragment surface areas generated regularly
increasing CL emissions up to a maximum at 12.8 cm2/ml
MS/BV ratio. In contrast, CL produced in samples in contact
with PAN membranes remained extremely low and did not
increase with the MS/BV ratio.
in vitro effect of dialysis membranes on ROS production by
PMN cells from normal subjects
Table 3 shows the effects of CUP and PAN membrane
fragments on the production of ROS by PMN cells from normal
subjects. In this series of five experiments, PMN cells (3 x 10)
resuspended in 100 p,1 of HBSS were incubated with CUP or
Incubation time, mm
Fig. 6. In vitro kinetic study of the effect of dialysis membranes on ROS
production by normal whole blood (mean CL SEM from six experi-
ments). In each experiment, undiluted blood samples were incubated at
37°C with CUP or PAN membrane fragments at a constant MS/BV ratio
of 10 cm2/ml (or without membrane fragments for controls) for the
various time periods indicated on the abcissa. At the end of these
incubation periods, CL responses were determined in triplicate 100 p1
aliquots of the treated blood. Symbols are: •, CUP membrane; A, PAN
membrane; 0, no membrane.
Blood dilution
Fig. 7. In vitro study of the effect of dialysis membranes on ROS
production by normal whole blood, tested at serial blood dilutions
(mean CL SEM from six experiments). In each experiment, blood
samples (from pure to l02 diluted) were incubated at 37°C with CUP or
PAN membrane fragments at a constant MS/BV ratio of 10 cm2/ml (or
without membrane fragments for controls). After a 30-mm incubation,
CL responses were determined in triplicate aliquots (100 p1) of the
treated blood. Symbols are: •, CUP membrane; A, PAN membrane;
0, no membrane.
PAN membrane fragments of 1 cm2 at 37°C for 15 or 30 mm and
CL was measured as usual. CL emission by PMN cells was
much higher in the presence of CUP than PAN membrane
fragments; however, the differences observed between the two
membranes are statistically significant only for the series incu-
bated for 30 mm (P < 0.01 with the paired t test). The moderate
increase in CL production in the presence of PAN, compared to
its level in the absence of membrane, is not statistically signif-
icant, whereas the differences observed between PMN cells
Table 1. Investigation of ROS production by PMN cells from
dialyzed patients: comparative study between patients dialyzed
with cuprophane or polyacrylonitrile membranes
2
1
C0
0
00
C.
C)
5 15 30 120 240
Autologous to plasma 8.7 2 12.2 9.5 5.8 1 8.9 2.3
Autologous ti plasma 23.8 4.8 27.7 5.3 7.24 1.4 7.5 2.2
Abbreviations are the same as Table I.
a P <0.01.
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Fig. 8. Influence of membrane surface area on membrane dialysis-
induced effect on ROS production by normal whole blood (mean CL
SEM from three experiments). In each experiment, 10 diluted blood
samples were incubated at 37°C with CUP or PAN membrane fragments
at increasing MS/BY ratios, as indicated on the abcissa (or without
membrane fragments for controls). At the end of the incubation, CL
responses were determined in triplicate aliquots (100 pJ) of the treated
blood. Symbols are: , CUP membrane; , PAN membrane.
Fig. 9. In vitro study of the influence of plasma on dialysis membrane-
induced ROS production as illustrated by a typical experiment (mean
CL SEM of triplicate samples). For this study, plasma samples (4 ml)
were incubated for 30 mm at 37°C with CUP or PAN membrane
fragments (at a MS/plasma volume ratio of 20 cm2/ml) or without
membrane fragments for controls. Subsequently, 50 d plasma aliquots,
membrane-treated or not, were incubated with equal volumes of a
suspension of autologous PMN cells (6 x 106/ml) for the various times
as indicated on the abcissa and CL responses were measured. Symbols
are: •, CUP membrane; A, PAN membrane; 0, no membrane.
Table 3. Generation of ROS by PMN cells from normal subjects
following in vitro incubation at 37°C with dialysis membranes
Mean CL production
incubation for
SEM after
15 mm 30 mm
CUP membrane
10 cm/ml
PAN membrane
10 cm2/ml
No membrane
55894 13846
NS
31496 11199
NS
19477 4777
28264 5191
P < 0.01
8277 2498
NS
5947 1464
10
8
6
N
>
C0
'O0
0.
-J
c)
C0
0
0
a
-J0
2
5 15 30 60
Incubation time, mm
0.2 0.4 0.8 1.6 3.2 6.4 12.8 25.6
Membrane surface/101 diluted blood volume, cm2/mI
incubated with CUP or no membranes are highly significant (P
<0.001), regardless of the time of incubation.
Effect of in vitro dialysis membrane-treated plasma on ROS
production by autologous PMN cells
Figure 9 compares the capacities of CUP and PAN
membrane-treated normal plasma to trigger the release of ROS
from their autologous PMN cells. In this typical experiment,
PMN cells (3 x l0) were incubated with autologous plasma
treated previously with membrane fragment according to a
technical protocol described in the legend of the figure, and CL
was determined at increasing time intervals, As shown in this
figure, CL produced by PMN cells is significantly higher in the
presence of CUP- than PAN-treated plasma (P < 0.001).
However, as compared to untreated plasma, PAN-treated
plasma induced a moderate CL response also (P < 0.05).
Interestingly, (results not shown on this figure) we could
verify that complement inactivation by heating the plasma at
56°C for 30 mm prior to dialysis membrane treatment abolishes
Discussion
We reported previously that luminol-dependent CL is an
ultrasensitive means for measuring the activation of phagocyte
oxidative metabolism induced by non-specific membrane stim-
uli [15, 17—19], as well as more physiological plasma substances
such as antibodies [20, 21], We had shown also that CL
production, which is known to be due to the generation of
excited ROS by phagocytic cells and to be a property restricted
to these cell types [22], can be monitored easily and accurately
within whole blood [15], as well as isolated phagocytic cells
[19], and is influenced diversely in clinical situations [17, 18].
The present study is an extensive investigation of CL pro-
duction within whole blood and isolated PMN cells from
the effect of membranes completely. dialyzed patients, which is focused particularly on the influence
Hemodialysis-induced changes in phagocyte oxidative metabolism 165
of dialysis membranes. As a result of the multiple parameters
involved in this phagocyte oxidative function, the discussion of
our findings has been subdivided to clarify the data and its
possible implications in the field of dialysis.
Stud p of ROS production before the start of the
dialysis session
We found that phagocytes from dialyzed patients compared
to those from normal individuals demonstrated decreased ca-
pacity to produce ROS when tested in 10-2but not 10' diluted
blood. These results may be related to the known increased
susceptibility of dialyzed patients to bacterial infections [1, 2]
and to other reports showing that phagocytic cells of uremic
patients have impaired phagocytosing capacity [23—25]. Indeed,
this decreased ROS production was found in the presence of
particulate agents such as latex particles, which stimulate
phagocyte oxidative metabolism by means of a cell surface
charge interaction, as well as opsonized zymosan, which acts
by combining with membrane receptors for IgG and C3b [261
and thus mimics membrane/bacteria interactions. It was ob-
served also with a soluble stimulus such as PMA, which is a
well-characterized co-carcinogen derived from croton oil that
induces metabolic alterations similar to those seen during
phagocytosis [27].
Interestingly, we found that ROS production measured in
higher plasma concentrations (10—' diluted blood) did not
significantly differ between patients and normal subjects and
that at both plasma concentrations tested, normal CL responses
were observed with FLMP, the chemotactic peptide that stim-
ulates the phagocyte respiratory burst via its direct binding to
specific membrane receptors [28]. A possible overall explana-
tion could 1e the presence of plasma substances capable of
interacting with either the triggering of the oxidative reactions
or their detection [29].
Predialysis PMN phagocytes isolated from whole blood
showed decreased ROS generation also when stimulated with
opsonized zymosan, which could reflect an impaired PMN
phagocytic capacity. Their native CL production, as well as
that triggered by PMA, were within the normal range. This
finding, which is in disagreement with our observation in whole
blood and the data of Ritchey obtained with isolated PMN cells
[8], needs to be elucidated further. Kinetic studies of the
reactions using isolated PMN and MN phagocytes are in
progress in our laboratory currently.
Study of ROS production during the course of the
dialysis session
In the absence of stimulating agents. Fifteen mm after the
initiation of dialysis, a dramatic increase in resting CL genera-
tion was observed in whole blood and at both low and high
plasma concentrations. By the end of the session, CL produc-
tion returned to its predialysis level.
Interestingly, this peak of CL emission observed at ti oc-
curred simultaneously with the nadir recorded in the blood
phagocyte count. The fact that whole blood CL measurements
must be expressed on a per cell basis in order to compare CL
results between distinct groups of individuals [15] may raise the
question of a calculation artifact at the origin of the increased
adjusted CL values.
Measured CL values appeared to be unchanged between to
and ti (respectively 64 11 vs. 60 14 in l0', and 66 12 vs.
41 4 in 102 diluted blood). Thus, if measured rather than
adjusted CL values are to be considered, it must be explained
how CL production can remain unchanged despite a fivefold
drop in the number of CL-producing cells.
Since CL production in diluted blood is increased at ti
regardless of the mode of expression, the two following expla-
nations are proposed.
In the first proposed explanation, increased ROS generation
could be due to the remaining presence of a more highly
reactive, ROS-producing phagocyte subpopulation following
the pulmonary bed sequestration of phagocytes reported com-
monly to be at the origin of dialysis-induced leukopenia [11].
This hypothesis has been studied on different phagocyte func-
tions during dialysis [30]. However, it is not supported by our
results, which show that resting CL production by phagocytes
separated from whole blood did not significantly differ between
to and ti.
The second or alternative explanation could be the presence
of substances in the plasma that activate the phagocyte oxida-
tive metabolism. Among these, activated complement compo-
nents, which are known to appear early in the course of the
dialysis session [11—13] and to be potent stimuli of ROS release
by phagocytic cells [31], could be involved. The unaltered CL
production by isolated PMN cells found between to and ti
supports further the possibility that a circulating plasma sub-
stance may be the source of the increased ROS generation in
whole blood. Our results from tests cross incubating patient
cells isolated at to and autologous ti plasma, which are dis-
cussed below, favor this hypothesis strongly.
In the presence of stimulating agents. In contrast with resting
CL, stimulated CL production at ti was not increased, and even
appeared decreased, with the soluble agent PMA. At the end of
the session, both zymosan- and PMA-induced CL responses
were found to be significantly increased compared to their ti
levels, while neither latex- nor FMLP-induced CL responses
varied significantly during the course of the session. Such
dissociations in CL responses according to the nature of the
membrane stimulus have been observed previously in other
clinical situations investigated in our laboratory [32]. The fact
that neither zymosan- nor PMA-induced CL responses were
altered in PMN cells isolated from whole blood suggests that
the above-mentioned plasma substances generated between to
and ti may interfere in the interactions between phagocyte
membranes and some but not all stimulating agents.
Influence of dialysis membranes on phagocyte
oxidative metabolism
Our in vivo studies demonstrated that CUP membranes can
be responsible for the alterations observed in phagocyte counts
as well as oxidative metabolism. In contrast, PAN dialysis
membranes appear to be biocompatible almost totally, since
patients dialyzed with these membranes showed no significant
changes in either leukocyte counts or phagocyte oxidative
metabolism capacities. Similar observations have been reported
by other authors investigating the effects of dialysis membranes
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on other cell functions and/or plasma properties [22, 33, 34].
The remarkably superior biocompatibility of PAN over CUP
membranes was demonstrated further in our in vitro studies on
the effect of these membranes on CL production in whole blood
from normal subjects. We showed that the kinetics of
phagocyte oxidative metabolism activation induced in vitro by
CUP membranes follows closely that observed in vivo, with a
maximum between 15 and 30 mm following the beginning of
contact between the blood and the membrane, and that there
was an almost linear relationship between the intensity of whole
blood CL generation and the CUP membrane surface in contact
with the blood.
This dose-dependent effect of the CUP membrane suggested
the participation of activated plasma components in the in vitro
induced activation of whole blood phagocyte oxidative metab-
olism. This was verified further in our experiments demonstrat-
ing that CUP-, but not PAN-, treated plasma triggered ROS
generation by isolated PMN cells. Among these plasma sub-
stances, activated complement components, which are known
to be generated following in vitro incubation of normal plasma
with CUP but not PAN membranes [14, 34], were the first to be
investigated. We found that simple heat inactivation of plasma
abrogated completely this effect of CUP membrane-treated
plasma and/or serum.
Nevertheless, our experiments showing that the oxidative
metabolism of PMN cells isolated from whole blood also could
be triggered in vitro by a CUP but not a PAN dialysis mem-
brane, without addition of plasma or serum, may suggest also
that the effect of the CUP membrane on whole blood reflects a
combined action on plasma and cell membranes. However, it is
still possible that this effect on isolated PMN cells could be
mediated via cell bound activated complement components.
This latter hypothesis, as well as the effect of these dialysis
membranes on isolated MN, remains to be investigated to
further elucidate the effect of dialysis membranes on phagocyte
oxidative metabolism.
Lastly, we suggest that this ultrasensitive and accurate
method for evaluating membrane biocompatibility by the direct
measurement of phagocyte ROS production within micro-
amounts of whole blood could be applied also to other models
of extracorporeal blood circuits. For example, in a prospective
collaborative study of the deleterious effects of cardiopul-
monary bypass, we demonstrated recently that this model
distinguishes between the effects induced by bubbles, as op-
posed to membrane oxygenation [35]. However, due to the
numerous pathways of triggering phagocyte oxidative re-
sponses, great care must be taken when interpreting the ob-
served effects.
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